About this item:

213 Views | 219 Downloads

Author Notes:

Cassandra L. Quave, cquave@emory.edu

CQ, FC, and JL conceived and designed the experiments.

XH, FC, and JL performed the experiments.

XH and FC analyzed the data.

FC, XH, CQ, and JL wrote the manuscript.

All authors helped to finish the manuscript and approved the final manuscript.

The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain 5-143 (OIFC143), NR-17781.

The following reagent was obtained through BEI Resources, NIAID, NIH: Klebsiella pneumoniae, Isolate 1, NR-15410.

Thanks to Mark Smeltzer for providing S. aureus strains UAMS-1 and UAMS-929; and to Alex Horswill for S. aureus strains AH430 and LAC.

We would also like to thank Dr. Kraft and the clinical microbiology laboratory at Emory University Hospital for running the antibiotic susceptibility tests for creation of comprehensive antibiograms on strains used in this study.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Subjects:

Research Funding:

This work was supported by a grant from the National Institutes of Health, National Institute of Allergy and Infectious Disease (R21 AI136563, PI: CQ).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Microbiology
  • Ginkgo
  • TCM
  • ginkgolic acid
  • skin infections
  • ESKAPE
  • NATURAL-PRODUCTS
  • ANTIBACTERIAL ACTIVITY
  • SYNERGISTIC INTERACTIONS
  • ACINETOBACTER-BAUMANNII
  • EXTRACTS
  • INFECTIONS
  • PLANTS
  • ACIDS
  • SKIN
  • CYTOTOXICITY

Validation of a 16th Century Traditional Chinese Medicine Use of Ginkgo biloba as a Topical Antimicrobial

Tools:

Journal Title:

Frontiers in Microbiology

Volume:

Volume 10

Publisher:

, Pages 775-775

Type of Work:

Article | Final Publisher PDF

Abstract:

In the search for new therapeutic solutions to address an increasing number of multidrug-resistant bacterial pathogens, secondary metabolites from plants have proven to be a rich source of antimicrobial compounds. Ginkgo biloba, a tree native to China, has been spread around the world as an ornamental tree. Its seeds have been used as snacks and medical materials in Traditional Chinese Medicine (TCM), while over the last century its leaf extracts emerged as a source of rising pharmaceutical commerce related to brain health in Western medicine. Besides studies on the neuro-protective effects of Ginkgo, its antibacterial activities have gained more attention from researchers in the past decades, though its leaves were the main focus. We reviewed a 16th-century Chinese text, the Ben Cao Gang Mu by Li Shi-Zhen, to investigate the ancient prescription of Ginkgo seeds for skin infections. We performed antibacterial assays on various Ginkgo seed extracts against pathogens (Staphylococcus aureus, Cutibacterium acnes, Klebsiella pneumoniae, Acinetobacter baumannii, Streptococcus pyogenes) relevant to skin and soft tissue infections (SSTIs). We demonstrate here that Ginkgo seed coats and immature seeds exhibit antibacterial activity against Gram-positive skin pathogens (C. acnes, S. aureus, and S. pyogenes), and thus validated its use in TCM. We also identified one compound tied to the antibacterial activity observed, ginkgolic acid C15:1, and examine its toxicity to human keratinocytes. These results highlight the relevance of ancient medical texts as leads for the discovery of natural products with antimicrobial activities.

Copyright information:

© 2019 Chassagne, Huang, Lyles and Quave.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote